SOURCE: EHE International; Histiocytosis Association of America

EHE International; Histiocytosis Association of America

EHE International; Histiocytosis Association of America

January 05, 2011 14:13 ET

EHE International and the Histiocytosis Association of America Want You to "Know the Cold Facts" About Histiocytosis

PITMAN, NJ--(Marketwire - January 5, 2011) - EHE International and the Histiocytosis Association of America (HAA) are excited to announce the unveiling of a window display at 10 Rockefeller Plaza encouraging Americans to "Know the Cold Facts" about histiocytosis. Characterized by a build-up of white blood cells known as histiocytes, histiocytosis is a rare and potentially fatal blood disorder. The window will prominently feature information from the HAA's public awareness campaign including the cold facts about histiocytosis.

"This opportunity will raise awareness among the public about the plight of histiocytosis and the need for federal research funding," said Executive Director Jeffrey Toughill. "It is important to know that the pain and suffering experienced by people with this disorder can be just as severe as that of people diagnosed with more prevalent diseases, such as leukemia. With the help of the public, physicians, and the family members and friends of patients with histiocytosis, we are able to offer hope for better treatments and a cure for all who suffer from this disorder."

The window will be on display for the public from January 3 until January 31. "EHE is pleased to offer the Histiocytosis Association of America this window in order to raise awareness for the need of better treatments and a cure of this rare, yet important, disease," said Deborah McKeever, EHE President.

In addition to the faces of patients, the window will include important facts about histiocytosis. Approximately 1 in 560,000 adults and 1 in 200,000 children are diagnosed with the disorder in the United States each year. Histiocytosis is classified as an "orphan disease," because it affects too few people to receive substantial government funding for research. Through its annual grant program, the HAA provides financial support to researchers studying the causes and treatment of the disorder.

Founded in 1986, the Histiocytosis Association of America is dedicated to raising awareness about histiocytic disorders, providing educational and emotional support, and funding research leading to better treatments and a cure. You can learn more about the HAA and histiocytosis at the HAA's website, www.histio.org. The site offers a variety of educational and emotional support services and information for patients diagnosed with histiocytosis, their friends and family members, physicians, and members of the public.

Since 1913, EHE International has been the recognized leader in preventive medicine. Its clinical protocols are specifically designed for the early detection of preventable disease and its associated risk factors, supported by robust personal coaching, wellness tools and resources, and its industry leading educational and social engagement platforms. The company is well-known for its corporate-sponsored employee benefit, "EHE & Me," a patient-centered approach to preventive care and life-style management programs specifically designed for integration into self-funded employer-sponsored medical plans.

For more information, contact EHE International, 10 Rockefeller Plaza, 4th Floor, New York, New York 10020; 212.332.3705; www.EHEandMe.com

Contact Information

  • Contact:
    Nicolas Danielides
    Danielides Communications
    Phone: 212-319-7566
    Email: Email Contact

    Contact:
    Jeffrey Toughill
    Histiocytosis Association of America
    Phone: 856-589-6606
    Email: Email Contact